Back to Results

STRATA Skin Sciences Inc (SSKN)

STRATA Skin Sciences, Inc. is a healthcare equipment company focused on medical technology for dermatologic conditions. The common stock is listed on OTC Markets under the ticker SSKN. The company develops, commercializes, and markets treatment systems in the United States and internationally, including China, Europe, the Middle East, Asia, Australia, South Africa, and Central and South America. Its product lineup includes the XTRAC excimer laser and VTRAC lamp systems, which are used in treating psoriasis, vitiligo, and other skin disorders, as well as the TheraClear acne therapy system for mild to moderate inflammatory, comedonal, and pustular acne. STRATA Skin Sciences serves dermatologists and dermatology group clinics. Founded in 1989 and headquartered in Horsham, Pennsylvania, the company was previously known as MELA Sciences, Inc. before adopting its current name in January 2016.


Stock Summary Fair Value Profitability & Growth Quality & Risk Events & Dividends Market Outlook FAQ

Jump directly to the stock analysis sections supported by the latest available data.

Data update note: Fair value and stock analysis metrics are updated after regular market sessions when new data becomes available.
Ticker Fair Value Analyst Price Target Analyst Target Upside/Downside Analyst Target Rating Overall Financial Health Dividend Yield Next Earnings Date Market Cap Enterprise Value Total Debt / Total Capital Free Float / Shares Outstanding Altman Z-Score Free Cash Flow / Net Income
OTC-SSKN
Not available
$10.80 10,799,900.0% Upside
Not available
Bargain
Weak
0.0%
December 24, 2026
0.588 K
8.357 M
100.0%
68.9%
-13.9
68.1%
Valuation • Fair Value

STRATA Skin Sciences Inc (OTC-SSKN) Fair Value by Valuation Model

Review the available estimates for STRATA Skin Sciences Inc (OTC-SSKN), including Comps Fair Value.

Primary Valuation Read

Fair Value

Not available

Data is currently unavailable.

Comps Fair Value

$0.00010

Comparable-company valuation reference.

Analyst Price Target

$10.80 10,799,900.0% Upside

Current consensus analyst target, where available.

How to read these valuation models

Use the 2 available valuation references for STRATA Skin Sciences Inc (OTC-SSKN) as analytical inputs, not a standalone conclusion. Valuation methods can differ because they rely on different assumptions, time horizons and financial inputs; compare the estimates with the current price and the company’s financial quality.

Profitability • Growth

Profitability & Growth for STRATA Skin Sciences Inc (OTC-SSKN)

Review the profitability and growth indicators currently supported by the latest data.

Revenue

30.696 M

Current operating scale indicator.

Revenue Forecast

32.78 M

Forward revenue estimate.

EBITDA

-1.712 M

Current operating profitability reference.

EBITDA Forecast

1.8 M

Forward operating profitability estimate.

How to read profitability and growth

This section helps investors review STRATA Skin Sciences Inc (OTC-SSKN) from an operating perspective by combining current scale, forward revenue expectations and EBITDA-related profitability measures.

Quality • Risk

Quality & Financial Risk for STRATA Skin Sciences Inc (OTC-SSKN)

Review the financial quality and risk indicators currently supported by the latest data.

Financial Health

Weak

Financial pressure deserves closer review.

Piotroski Score

4

Mid-range quality score.

Beneish M-Score

-3.52

No elevated caution signal from this screen.

Altman Z-Score

-13.9

Lower score that deserves closer risk review.

FCF / Net Income

68.1%

Cash conversion quality indicator.

How to read quality and risk

This section combines quality, balance-sheet and accounting-risk indicators for STRATA Skin Sciences Inc (OTC-SSKN). Read the metrics together: no single score is a complete investment conclusion, but the combined view can highlight financial strength, earnings quality and areas that may deserve closer review.

Events • Dividends

Upcoming Events & Dividends for STRATA Skin Sciences Inc (OTC-SSKN)

Track the upcoming dates and dividend metrics currently supported by the latest data.

Next Earnings Date

December 24, 2026

Days to Earnings

48

Dividend Yield

0.0%

No current dividend yield is indicated.

How to read events and dividends

This section helps investors track time-sensitive items for STRATA Skin Sciences Inc (OTC-SSKN), including the next earnings date and dividend-related milestones. These items can matter for short-term volatility, income planning and event-driven positioning.

Stock Forecast • Technical Outlook

STRATA Skin Sciences Inc (OTC-SSKN) Stock Forecast & Technical Outlook

Review STRATA Skin Sciences Inc (OTC-SSKN) across multiple technical time frames, alongside analyst recommendation data, to form a faster read on market positioning and near-term sentiment.

Technical Signals by Time Frame

Switch between time frames to review the current technical signal for the stock.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: 15-minute • intraday
Strong Sell

The 15-minute technical read for STRATA Skin Sciences Inc (OTC-SSKN) is currently Strong Sell. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: 1-hour • short-term
Strong Sell

The 1-hour technical read for STRATA Skin Sciences Inc (OTC-SSKN) is currently Strong Sell. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: daily • daily
Strong Sell

The daily technical read for STRATA Skin Sciences Inc (OTC-SSKN) is currently Strong Sell. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: weekly • weekly
Strong Sell

The weekly technical read for STRATA Skin Sciences Inc (OTC-SSKN) is currently Strong Sell. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: monthly • monthly
Strong Sell

The monthly technical read for STRATA Skin Sciences Inc (OTC-SSKN) is currently Strong Sell. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Analyst Consensus for STRATA Skin Sciences Inc (OTC-SSKN)

A consolidated view of buy, hold and sell recommendations based on the currently available analyst data.

Strong Sell Sell Neutral Buy Strong Buy
Consolidated analyst recommendation mix
Strong Buy

Based on the available recommendation mix, STRATA Skin Sciences Inc (OTC-SSKN) has a Strong Buy consensus, with 1 buy, 0 hold and 0 sell recommendations in the current data set.

Buy 1
Hold 0
Sell 0
FAQ • Fast Investor Answers

STRATA Skin Sciences Inc (OTC-SSKN) Stock FAQ

Data-supported answers about STRATA Skin Sciences Inc (OTC-SSKN), including explicit coverage status where a reliable valuation estimate is not currently available.

Fair Value
Not available
No reliable estimate from the currently supported inputs
Analyst Target
$10.80 10,799,900.0% Upside
Data is currently unavailable
Financial Health
Weak
Current financial-health read

A reliable fair value estimate is not currently available for STRATA Skin Sciences Inc (OTC-SSKN). This generally means the latest dataset does not contain enough valid inputs for the valuation models supported by PriceToWorth. The site does not substitute zero or publish an unsupported estimate; availability may change when updated financial data or applicable model inputs become available.

The available analyst price target for STRATA Skin Sciences Inc (OTC-SSKN) is $10.80 10,799,900.0% Upside.

The current financial health read for STRATA Skin Sciences Inc (OTC-SSKN) is Weak. This should be reviewed alongside valuation, profitability, debt and cash-flow quality metrics.

The next earnings date currently listed for STRATA Skin Sciences Inc (OTC-SSKN) is December 24, 2026.

The latest available data indicates no current dividend yield for STRATA Skin Sciences Inc (OTC-SSKN).

The current market capitalization listed for STRATA Skin Sciences Inc is 0.588 K.

The current enterprise value listed for STRATA Skin Sciences Inc is 8.357 M. Enterprise value can provide a broader valuation view than market capitalization alone because it also considers net debt.

The ticker symbol for STRATA Skin Sciences Inc is OTC-SSKN, and the stock is listed on OTC Markets.

STRATA Skin Sciences Inc (OTC-SSKN) is listed on OTC Markets.

The current debt-to-total-capital ratio listed for STRATA Skin Sciences Inc is 100.0%, which helps investors evaluate the company’s financing structure and leverage profile.

The free float listed for STRATA Skin Sciences Inc is 68.9%. Free float helps investors understand how much of the share base is available for public trading.

Similar Healthcare Equipment & Supplies Stocks View more on OTC Markets

Comparable companies from the same industry, limited to one security per issuer.

ABT NYSE Abbott Laboratories Fair Value Fair Market Cap 196.7 B
ISRG NASDAQ Intuitive Surgical Inc Fair Value Fair Market Cap 162.4 B
MDT NYSE Medtronic PLC Fair Value Fair Market Cap 128.3 B
SYK NYSE Stryker Corporation Fair Value Fair Market Cap 127.6 B
BSX NYSE Boston Scientific Corp Fair Value Undervalued Market Cap 64.704 B
BDX NYSE Becton Dickinson and Co Fair Value Fair Market Cap 58.168 B
EW NYSE Edwards Lifesciences Corp Fair Value Fair Market Cap 57.971 B
IDXX NASDAQ IDEXX Laboratories Inc Fair Value Fair Market Cap 52.86 B
MDLN NASDAQ Medline Inc Fair Value Fair Market Cap 52.302 B
GEHC NASDAQ GE HealthCare Technologies Inc Fair Value Fair Market Cap 37.867 B
ALC NYSE Alcon AG Fair Value Fair Market Cap 37.14 B
RMD NYSE ResMed Inc Fair Value Fair Market Cap 33.661 B
DXCM NASDAQ DexCom Inc Fair Value Undervalued Market Cap 31.503 B
PHG NYSE Koninklijke Philips NV ADR Fair Value Fair Market Cap 30.181 B
STE NYSE STERIS plc Fair Value Fair Market Cap 24.777 B
ZBH NYSE Zimmer Biomet Holdings Inc Fair Value Fair Market Cap 20.222 B
SOLV NYSE Solventum Corp Fair Value Fair Market Cap 14.84 B
SNN NYSE Smith & Nephew SNATS Inc Fair Value Undervalued Market Cap 13.319 B
BAX NYSE Baxter International Inc Fair Value Fair Market Cap 13.27 B
GKOS NYSE Glaukos Corp Fair Value Overvalued Market Cap 13.016 B